Allovir, Inc. (KLRS) — SC 13G/A Filings
All SC 13G/A filings from Allovir, Inc.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Aug 2, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Artal International Amends AlloVir Stake as of Dec 31, 2023
— Feb 9, 2024 Risk: low
Artal International S.C.A. and its affiliated entities, including Artal Group S.A. and Invus Public Equities, L.P., filed an amended Schedule 13G/A for AlloVir, -
FMR LLC Cuts Allovir Stake to 4.99%; Holds 5.69M Shares
— Feb 9, 2024 Risk: medium
FMR LLC, a major investment management firm, and its principal owner, Abigail P. Johnson, have reduced their beneficial ownership in Allovir, Inc. (NASDAQ: ALVR -
John R. Wilson Maintains 3.16M Share Stake in Allovir (ALVR)
— Jan 9, 2024
John Robert Wilson, an individual, filed an amended SC 13G/A on January 9, 2024, disclosing his beneficial ownership in Allovir, Inc. (ALVR). Wilson reported so
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX